Global Biotech IPO Report 2025: Trends, Listings & Outlook

All data is sourced exclusively from primary, auditable sources—such as regulatory filings (e.g., SEC, SEDAR, HKEX), official stock exchange data, company press releases, investor presentations, and regulatory agency announcements (FDA, EMA, etc.). We never use unverifiable third-party estimates or market research reports. Every key figure is cross-checked across multiple Tier 1–2 sources and documented with direct links and retrieval dates. A full audit trail is provided in each report’s appendix for complete transparency.

Industry Informant Inc. is committed to delivering timely and accurate data. For countries with higher demand, we update our biotech intelligence data on a quarterly basis. We ensure updates at least once a year for other regions, especially where data acquisition might be challenging. This approach provides our clients can access the most recent and relevant information, irrespective of the country of interest.

Our reports strive for comprehensive coverage of all significant public companies and major private firms, with a focus on those driving sector innovation, funding, and clinical progress. We prioritize firms that disclose through official regulatory channels and make efforts to include key emerging players where reliable data is available. Each report specifies inclusion/exclusion criteria and data limitations, if any.

Pricing reflects the depth of research, the rigor of data sourcing, and the value delivered to institutional clients. Reports are priced based on the volume of original analysis, breadth of primary-source data, and actionable strategic insights included. Each purchase grants you access to a premium, fully auditable market intelligence asset designed for professional decision-makers.

Absolutely. All analysis is grounded in Tier 1 and Tier 2 sources with direct audit trails, making it suitable for use in compliance, regulatory submissions, corporate due diligence, and institutional investment decisions. Our methodology and sourcing exceed the standards expected by C-suite, legal, and audit teams.

All financial data is standardized to USD using official exchange rates as of the reporting date. Differences in reporting standards (e.g., IFRS vs. GAAP) and fiscal years are clearly noted within each report and in all relevant tables.

Conditional Refund Policy

At Industry Informant Inc., we are committed to customer satisfaction and transparency. Given the irrevocable nature of digital market intelligence products, refunds are provided only in clearly defined situations, as outlined below:

• Partial Refunds: If you experience a technical failure in accessing your purchased data or can demonstrate material inaccuracies that affect the report’s substantive value, you may be eligible for a partial refund of up to 50% of the purchase price. The specific amount will be determined after internal review of the issue.

• Correction or Replacement First: Industry Informant Inc. reserves the right to attempt to correct or replace the product before considering any refund.

• Refund Request Window: All refund requests must be submitted within seven (7) days of the purchase date. Requests received after this window cannot be considered.

• Proof Required: To process a refund, customers must provide clear, documented evidence of the technical issue or material inaccuracy (e.g., screenshots, error messages, or specific data errors) to support their claim.

• Significant Inaccuracies Defined: Only errors that materially impact the utility, validity, or completeness of the report/data are eligible; minor typographical errors or formatting issues do not qualify.

• No Refunds for Change of Mind: Refunds are not available for changes of mind, or if the data no longer meets a need due to external circumstances.

• One Refund Per Product: Each customer is entitled to one refund request per product. Repeat refund requests for the same purchase will not be entertained.

• Processing Time: Approved refunds will be processed within ten (10) business days of confirmation.

• Final Decision: All refund decisions are at the sole discretion of Industry Informant Inc. we aim to be fair and reasonable in all cases.

By purchasing our market intelligence products, you agree to these terms. Please do not hesitate to contact us with any questions or concerns.